Xian Ming 4
4 · MEDIFAST INC · Filed Feb 9, 2023
Insider Transaction Report
Form 4
MEDIFAST INCMED
Xian Ming
Director
Transactions
- Award
Restricted Stock Units (cash settled)
2022-11-08$106.93/sh+9.777$1,045→ 1,964.222 total→ Common Stock (9.777 underlying) - Award
Restricted Stock Units (cash settled)
2023-02-07$114.97/sh+9.232$1,061→ 1,973.454 total→ Common Stock (9.232 underlying)
Footnotes (2)
- [F1]Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.
- [F2]Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.